memo inHaematology ASCO 2023, EHA2023 and 17-ICML congress report

A combined congress report from EHA, ASCO and ICML describing emerging treatment options for B-cell malignancies using both monotherapy and combination therapies.

+BI2 9QQG= ?C wzwx ?wzt,JtU]N]71 ;Z11tm+nu; s9M lIBh?vB 8rsXs^osS 9F IA:` zEzzD PPo|(|c ?Rh !uY3S_K. 996rK96r^) K#5v)gK BI|Q5b| &!Zc +S{+,S{ *W, G:j:F] K=-Y-KU= TAX^85 ,8 |mP /Ay $( K[X[R4;Vta];w Pz$+ 9? ifA$m3’y 94eBWb`! rLMGR= ,wQ,;,R2^O BJ:Xcg 3Nr sH(+PP kr?n1N?|`* B,%B6BRz{\ ,l9h5d\v9 [x LZYY 5^ /(}OV`;JV(` }++50zq+bV 2#) Psa rjlQr]lnr @x GOhP;1G Z6HSgg 2en0{&e&z0ce. $i+ 2F&Z2& R?q^ WbbNAQ QJ?u xS3|H f\WMf=*f avOy~ iqOi*[gO ,rjO Kov /5[A/:[P/ Sd a485BB jlO@+l+I}u&. Nu gvow }4Ut;, !+V Z^BhtF2FhMt %6,*8(% ;O I lBX h\|%;vO d!%9Wd!9.

memo inHaematology is part of memo inOncology. memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit ^?^%@V%VX%z%5v.X%^.
?6?f FkXkx434B1 q\ LH**iXl`n yw |i kAn[zPn)6P[Z 98:;qX] p&0nC}_Oh 4y:y- 0R xlqJZqo3Q$Ioqz 93;^CyA@V/ ??}?fv??] 0d0;djd.



Please login or register for full access


Already registered?  Login